Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph U Correll

Showing results (41-50 of 1,040) with videos related to

Pageof 104
Sort By:
The Journal of Clinical Psychiatry|March 23, 2026
Life After Clozapine: Managing Treatment-Resistant Schizophrenia When Clozapine Is No Longer an OptionJulieta Ramirez, Christoph U Correll
The Journal of Clinical Psychiatry|March 24, 2018
Tardive Dyskinesia: Recognition, Patient Assessment, and Differential DiagnosisRakesh Jain, Christoph U Correll
The Journal of Clinical Psychiatry|March 6, 2018
Long-Acting Injectable Antipsychotics: Where Do They Fit in the Treatment Plan?Christoph U Correll, John Lauriello
Deutsches Arzteblatt International|May 26, 2020
Suicidality in Childhood and AdolescenceMerle Becker, Christoph U Correll
Evidence-Based Mental Health|October 20, 2011
Review: quetiapine monotherapy improves response and remission compared with placebo in generalised anxiety disorderMaren Carbon, Christoph U Correll
Journal of Child and Adolescent Psychopharmacology|December 15, 2011
Weight gain and metabolic risks associated with antipsychotic medications in children and adolescentsLawrence Maayan, Christoph U Correll
CNS Spectrums|November 19, 2014
Thinking and acting beyond the positive: the role of the cognitive and negative symptoms in schizophreniaMaren Carbon, Christoph U Correll
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|January 19, 2013
The significance of at-risk or prodromal symptoms for bipolar I disorder in children and adolescentsMarta Hauser, Christoph U Correll
CNS Drugs|April 27, 2013
Rational use of generic psychotropic drugsMaren Carbon, Christoph U Correll
Journal of the American Academy of Child and Adolescent Psychiatry|July 25, 2017
Polypharmacy in Youth Treated With Antipsychotics: Do Antidepressants or Stimulants Add to the Risk for Type 2 Diabetes?Christoph U Correll, Britta Galling
Pageof 104

Showing results (41-50 of 1,040) with videos related to

Sort By:
Pageof 104
The Journal of Clinical Psychiatry|March 23, 2026
Life After Clozapine: Managing Treatment-Resistant Schizophrenia When Clozapine Is No Longer an OptionJulieta Ramirez, Christoph U Correll
The Journal of Clinical Psychiatry|March 24, 2018
Tardive Dyskinesia: Recognition, Patient Assessment, and Differential DiagnosisRakesh Jain, Christoph U Correll
The Journal of Clinical Psychiatry|March 6, 2018
Long-Acting Injectable Antipsychotics: Where Do They Fit in the Treatment Plan?Christoph U Correll, John Lauriello
Deutsches Arzteblatt International|May 26, 2020
Suicidality in Childhood and AdolescenceMerle Becker, Christoph U Correll
Evidence-Based Mental Health|October 20, 2011
Review: quetiapine monotherapy improves response and remission compared with placebo in generalised anxiety disorderMaren Carbon, Christoph U Correll
Journal of Child and Adolescent Psychopharmacology|December 15, 2011
Weight gain and metabolic risks associated with antipsychotic medications in children and adolescentsLawrence Maayan, Christoph U Correll
CNS Spectrums|November 19, 2014
Thinking and acting beyond the positive: the role of the cognitive and negative symptoms in schizophreniaMaren Carbon, Christoph U Correll
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|January 19, 2013
The significance of at-risk or prodromal symptoms for bipolar I disorder in children and adolescentsMarta Hauser, Christoph U Correll
CNS Drugs|April 27, 2013
Rational use of generic psychotropic drugsMaren Carbon, Christoph U Correll
Journal of the American Academy of Child and Adolescent Psychiatry|July 25, 2017
Polypharmacy in Youth Treated With Antipsychotics: Do Antidepressants or Stimulants Add to the Risk for Type 2 Diabetes?Christoph U Correll, Britta Galling
Pageof 104